- >>> Experimental Medicine December 2010 issue
- >>> Experimental Medicine February 2011 issue
At the forefront of Developing Sirtuin Drugs - the Key to Success as a Biotech Venture Company -
George P. Vlasuk , Ph.D.
Sirtris Pharmaceuticals, a GSK company Chief Executive Officer
George P. Vlasuk , Ph.D.
- Sirtris Pharmaceuticals, a GSK company Chief Executive Officer
Sirtris Pharmaceuticals is one of the most successful biotech companies , pursuing drug discovery targeting Sirtuins to treat diseases associated with aging, such as type 2 diabetes, Alzheimer’s disease, and inflammatory diseases. Sirtris was founded in 2004 and acquired in 2008 by GlaxoSmithKline. Dr. Vlasuk has been leading Sirtris as CEO since 2009.
In this interview, Dr. Vlasuk talks about Sirtris' perspective for Sirtuin activators, its organization , and the key to success as a biotech company.
With online video clips (links shown below), we published his interview article in the February 2011 issue of Experimental Medicine.
We hope that the article and the video clips of Dr. Vlasuk’s interview will bring great inspiration to all our readers.
Interviewer：Shuji Hachisuka(Editor of Experimental Medicine, Yodosha,co., Ltd.) , Chihiro Sato, Ph.D. (Washington University School of Medicine)
Streaming Video Clips
HTML5 Version (for iPad/iPhone)
![[DIGEST]](/jikkenigaku/images/washu_digest.gif)
At the forefront of Developing Sirtuin Drugs - the Key to Success as a Biotech Venture Company -- George P. Vlasuk, Ph.D.
- 4:40 [January 20th, 2011]
![[1]](/jikkenigaku/images/washu_number_1.gif)
The challenges for developing Sirtuin drugs and a controversy over the mechanism of SIRT1 activator"- George P. Vlasuk, Ph.D.
- 8:41 [January 20th, 2011]
- From understanding complicated sirtuin biology to translating it to clinic [4:00] ／Perspectives on SIRT1 activator[4:15]
![[2]](/jikkenigaku/images/washu_number_2.gif)
Scientific Advisory Board at Sirtris as a Knowledge Base- George P. Vlasuk, Ph.D.
- 6:34 [February 1st, 2011]
- The acquisition of Sirtris by GSK and the advantage for R&D[3:40] ／The scientific advisory system at Sirtris[2:26]
![[3]](/jikkenigaku/images/washu_number_3.gif)
Be a Risk Taker! ; The Key to Success as a Biotech Venture Company- George P. Vlasuk, Ph.D.
- 5:19 [February 8th, 2011]
- The key to making a successful biotech venture company[1:51] ／Messages for young scientists considering joining biotech industry[3:00]
